ADILENE ALVARADO: Open Payments
NPI 1205561891 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,404 in 68 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $654 · 2025 $1,404
Food & beverage: $1,404
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $253 |
| PFIZER INC. | 14 | $200 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $174 |
| ABBVIE INC. | 9 | $151 |
| Lilly USA, LLC | 6 | $136 |
| Axsome Therapeutics, Inc. | 4 | $92 |
| Phathom Pharmaceuticals, Inc. | 4 | $74 |
| Daiichi Sankyo Inc. | 2 | $57 |
| Esperion Therapeutics, Inc. | 3 | $49 |
| Dexcom, Inc. | 2 | $48 |
Products named: Wegovy, Kerendia, NURTEC ODT, QULIPTA, Auvelity, MOUNJARO, VOQUEZNA, INJECTAFER.
Industry payments across FL — which companies pay providers there.
